Deerfield Management Company L.P. Series C lessened its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 67.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,089,345 shares of the technology company’s stock after selling 2,277,000 shares during the quarter. Deerfield Management […]
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) were up 8.8% during mid-day trading on Tuesday . The company traded as high as $6.22 and last traded at $6.20. Approximately 930,129 shares changed hands during trading, a decline of 41% from the average daily volume of 1,573,280 shares. The stock had previously closed […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among brokerages […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.87 and traded as low as $4.30. Cogent Biosciences shares last traded at $4.38, with a volume of 1,172,921 shares. Wall Street Analyst Weigh In Several […]
Cogent Biosciences (NASDAQ:COGT – Get Free Report) was downgraded by investment analysts at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued on Monday, FinViz reports. They presently have a $5.00 price target on the technology company’s stock. Wedbush’s target price indicates a potential upside of 24.69% from the company’s […]